Director, Dp Workstream Leader – Small Molecule Parenteral (Lais And Oligos) in Stevenage

Director, Dp Workstream Leader – Small Molecule Parenteral (Lais And Oligos) in Stevenage

Stevenage Full-Time 80000 - 100000 £ / year (est.) No working from home possible
1

At a Glance

  • Tasks: Lead the development of innovative drug products and collaborate with cross-functional teams.
  • Company: Join GSK, a leader in science and technology dedicated to improving patient outcomes.
  • Benefits: Enjoy a hybrid working model, competitive salary, and comprehensive benefits.
  • Other info: Work in a collaborative culture with opportunities for growth and innovation.
  • Why this job: Make a meaningful impact on patients while advancing your career in a dynamic environment.
  • Qualifications: 8+ years in pharmaceutical project leadership; PhD preferred.

The predicted salary is between 80000 - 100000 £ per year.

Position Summary

The Director, DP Workstream Leader – Small Molecule Parenteral will lead the Drug Product (DP) workstream for sterile long-acting injectables (LAI) and oligonucleotide modalities.

In this role you will guide cross‑functional teams to design, develop and transfer robust sterile formulations and processes.

You will partner with clinical, regulatory, supply chain and external partners to deliver fit‑for‑purpose solutions.

We value curious scientists who are collaborative, clear communicators and who make data‑driven decisions to move projects forward.

This role offers growth, meaningful impact on patients and alignment with GSK’s mission of uniting science, technology and talent to get ahead of disease together.

The Late‑Phase Drug Product Workstream Leader (WSL) acts as the critical bridge between project strategy and functional execution, translating global Chemistry, Manufacturing, and Controls (CMC) and supply chain objectives into concrete functional plans.

Accountable for all CMC deliverables across one or multiple projects or assets, the WSL exercises expert matrix leadership: mobilizing, aligning, and empowering cross‑functional teams through influence, coordination, and deep subject‑matter expertise.

As the primary advocate for their discipline within the CMC Matrix Team, the WSL ensures collaboration, milestone achievement, and integrated solutions in even the most complex environments, maximizing organizational and patient impact.

The role is accountable for late‑phase project, meaning around the start of the development of Phase 3 or as agreed with the CMC Leaders.

Key Responsibilities

  • Lead late stage development for New Chemical Entities drug products, from formulation to presentation and device design/development.

Specifically lead Small Molecule programs for parenteral (e. g.

Long Acting Injectables), and/or for new modalities (Oligonucleotides).

  • Lead process development & scale‑up and technology transfer of drug product processes to manufacturing and packaging sites, ensuring robust and efficient production, including internal facilities and Contract Manufacturing Organizations (CMOs), as required.
  • Oversee formulation and fill‑finish process development, ensuring stability, compatibility, manufacturability, and product quality across clinical and commercial phases.
  • Coordinate clinical and commercial supply readiness by aligning R&D, manufacturing, and supply chain activities, translating clinical and regulatory strategies into actionable technical deliverables, and build robust control strategies via cross‑functional partnership.
  • Strategic

Alignment: Shape and align CMC and workstream strategies with program objectives, translating project priorities into clear functional direction and deliverables influencing other functions as required to deliver integrated solutions.

  • Functional
  • Matrix

Leadership: Act as the strategic interface between the CMC project and the function, ensuring technical excellence, operational readiness, and end‑to‑end delivery of CMC deliverables and Product Quality Deliverables (PQDs).

  • Risk and Compliance: Anticipate and mitigate risks across quality, supply, and compliance dimensions, maintaining business continuity and regulatory robustness.
  • Regulatory

Excellence: Provide authoritative functional input to CMC regulatory submissions and ensure alignment with global standards, policies, and best practices to develop and file a robust control strategy.

  • Cross‑Functional

Influence: Collaborate effectively across internal and external partners, driving alignment, accountability, and timely decision‑making within a complex matrix environment.

  • Technical
  • Thought

Leadership: Demonstrate scientific and operational leadership to elevate standards, streamline execution, and enable continuous improvement across the portfolio.

  • Critical thinking: Apply critical thinking to assess the validity of arguments and data, form well‑reasoned opinions, and challenge potential biases at all project levels to drive superior solutions.
  • Basic Qualification
  • Bachelor’s degree in Chemical/Biochemical Engineering, Chemistry, Biology, or related science discipline.
  • 8 or more years of experience in leading cross‑functional projects and matrix teams representing a transversal or functional CMC development team at one or more project team levels within the pharmaceutical or biotechnology industries.
  • 8 or more years of experience driving and executing on project strategies and the 360° aspects of medicine development, specifically for new chemical entities, their formulation and presentation.
  • Experience working with late-stage projects.
  • Preferred Qualification
  • Ph D in Chemical/Biochemical Engineering, Pharmaceutics, Chemistry, Biology, or related scientific discipline.
  • Experience with successful filing and approval would be advantageous.
  • Experience in late stage development of small molecule drug candidates for parenteral long‑acting injectables and/or oligonucleotides.
  • Demonstrated record of scientific achievement and a broad and integrated knowledge of the field.
  • Understanding of relevant regulatory and compliance standards.
  • Location and Working Model

This role may be based in the United States (Upper Providence, PA) or United Kingdom (Stevenage or Ware).

Working model: hybrid.

Regular on‑site collaboration is expected.

Remote work may be possible for focused tasks, but in‑person attendance is required for key meetings and team activities.

Please visit to learn more about the comprehensive benefits program GSK offers US employees.

GSK is an Equal Opportunity Employer.

This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

#J-18808-Ljbffr

Director, Dp Workstream Leader – Small Molecule Parenteral (Lais And Oligos) in Stevenage employer: 1925 GlaxoSmithKline LLC

At Closet America, a proud part of the Renuity family, we offer an exceptional work environment that fosters innovation and creativity. Our employees enjoy flexible schedules, comprehensive training, and ongoing support, ensuring personal and professional growth. Located in Raleigh, NC, our team thrives on collaboration and motivation, making it a rewarding place to build a meaningful career.

1

Contact Details:

1925 GlaxoSmithKline LLC Recruitment Team

We think you need these skills to ace Director, Dp Workstream Leader – Small Molecule Parenteral (Lais And Oligos) in Stevenage

Cross-Functional Leadership
Drug Product Development
Formulation and Process Development
Technology Transfer
Regulatory Compliance
Project Strategy Execution
Risk Management